JPS63101372A - Novel hydantoin derivative - Google Patents

Novel hydantoin derivative

Info

Publication number
JPS63101372A
JPS63101372A JP61246309A JP24630986A JPS63101372A JP S63101372 A JPS63101372 A JP S63101372A JP 61246309 A JP61246309 A JP 61246309A JP 24630986 A JP24630986 A JP 24630986A JP S63101372 A JPS63101372 A JP S63101372A
Authority
JP
Japan
Prior art keywords
formula
benzylidene
dioxo
acid
ester
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP61246309A
Other languages
Japanese (ja)
Other versions
JPH0798809B2 (en
Inventor
Toru Kobayashi
亨 小林
Takeshi Miyoshi
三芳 毅
Hideteru Kawashima
川島 英暉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Priority to JP61246309A priority Critical patent/JPH0798809B2/en
Priority to US07/038,364 priority patent/US4797493A/en
Priority to DE19873713094 priority patent/DE3713094A1/en
Priority to FR878705711A priority patent/FR2597476B1/en
Priority to KR1019870006755A priority patent/KR900002058B1/en
Publication of JPS63101372A publication Critical patent/JPS63101372A/en
Priority to US07/242,166 priority patent/US5000945A/en
Priority to US07/259,257 priority patent/US4985237A/en
Priority to US07/509,765 priority patent/US5087729A/en
Publication of JPH0798809B2 publication Critical patent/JPH0798809B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/445Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof aromatic, i.e. the carboxylic acid directly linked to the aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02Preparations containing skin colorants, e.g. pigments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02Preparations containing skin colorants, e.g. pigments
    • A61Q1/04Preparations containing skin colorants, e.g. pigments for lips
    • A61Q1/06Lipsticks
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/12Face or body powders for grooming, adorning or absorbing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/96Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having three double bonds between ring members or between ring members and non-ring members

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Artificial Filaments (AREA)

Abstract

NEW MATERIAL:A hydantoin derivative shown by formula I (X is H or -CH2- CH2CO2R; R is 3-18C alkyl, cyclohexyl or trimethylcyclohexyl). EXAMPLE:4-Benzylidene-2,5-dioxo-1,3-imidazolidinedipropionic acid diisopropyl ester. USE:An ultraviolet light absorber effective for preventing red spots on the skin, deterioration of resins, etc. PREPARATION:An aromatic aldehyde shown by the formula II is condensed with hydantoin shown by formula III in the presence of a basic catalyst to give benzalhydantoin shown by formula IV, to which an acrylic acid ester is subjected to Michael addition to give a compound shown by formula I.

Description

【発明の詳細な説明】 産業上の利用分野 本発明の化合物は、紫外線吸収剤として用いることがで
き、日焼は止め、繊維や樹脂等の黄変防止、容器及び包
材や、その内容物の紫外線からの保護等に有効であり、
塗料、樹脂、医薬、食品、化粧品といフた広い分野に対
し適応できる。
DETAILED DESCRIPTION OF THE INVENTION Industrial Fields of Application The compound of the present invention can be used as an ultraviolet absorber, preventing sunburn, preventing yellowing of fibers, resins, etc., containers and packaging materials, and their contents. It is effective in protecting from ultraviolet rays, etc.
It can be applied to a wide range of fields including paints, resins, medicines, foods, and cosmetics.

従来の技術 従来、化粧品の分野では紫外線の皮膚に対する有害作用
を防ぐ為、紫外線吸収剤が早くから注目され、数多く開
発されてきた。
BACKGROUND OF THE INVENTION Conventionally, in the field of cosmetics, ultraviolet absorbers have long attracted attention and have been developed in large numbers in order to prevent the harmful effects of ultraviolet rays on the skin.

紫外線吸収剤としては、ヘンシフエノン系吸収剤、サリ
チル酸系吸収剤、ケイ皮酸系吸収剤、バシアミノ安息香
酸系吸収剤などが、用いられている。しかしながら、上
述した紫外線吸収剤のうち、効果、安全性、溶解性、安
定性等を兼備するものは非常に少ない。
As the ultraviolet absorber, hensifenone-based absorbent, salicylic acid-based absorbent, cinnamic acid-based absorbent, bacyaminobenzoic acid-based absorbent, etc. are used. However, among the above-mentioned ultraviolet absorbers, there are very few that combine effectiveness, safety, solubility, stability, etc.

例えば、ベンゾフェノン系吸収剤は、320〜400n
mの長波長紫外線には吸収効果をもつが、火ぶくれなど
の原因と考えられている中波長紫外線(290〜320
nm)に対しては、吸収能が相対的に低い。
For example, benzophenone absorbent is 320 to 400n
It has an absorption effect on long-wavelength ultraviolet rays (290-320 m), but medium-wavelength ultraviolet rays (290-320 m), which are thought to cause blisters,
nm), the absorption capacity is relatively low.

バラアミノ安息香酸系、ケイ皮酸系吸収剤は、吸収効果
は高いが、安定性に問題があるといわれている。また、
サリチル酸系吸収剤は吸収効果が弱く、大量に配合しな
ければ効果が期待できない。
Barraminobenzoic acid-based and cinnamic acid-based absorbents have high absorption effects, but are said to have stability problems. Also,
Salicylic acid-based absorbents have a weak absorption effect and cannot be expected to be effective unless added in large quantities.

上述の紫外線吸収剤の他に紫外線を物理的に反射、散乱
させる機能を有する二酸化チタン、酸化亜鉛、酸化鉄な
どの無機粉体も用いられる。
In addition to the above-mentioned ultraviolet absorbers, inorganic powders such as titanium dioxide, zinc oxide, and iron oxide, which have the function of physically reflecting and scattering ultraviolet rays, are also used.

しかし、無機粉体は配合できる化粧品のタイプが限定さ
れ、また多量に配合する際に着色するという問題点があ
る。
However, inorganic powders are limited in the types of cosmetics that can be blended with them, and they also have the problem of coloring when blended in large amounts.

一方、樹脂の劣化を防ぐ為、紫外線吸収剤が添加剤とし
てもちいられている。樹脂の;n加削としては、サリチ
ル酸系、ヘンシフエノン系吸収剤の他、トリアゾール系
、シアノアクリレート系紫外線吸収剤が使用されている
。  しかしながら、サリチル酸系、およびベンゾフェ
ノン系吸収剤では、ポリエチレンやポリプロピレン、塩
化ビニル樹脂に影響をおよぼすといわれている300〜
32Onm付近の吸収が弱く、トリアソール系吸収剤は
安全衛生上問題があるといわれている。
On the other hand, ultraviolet absorbers are used as additives to prevent resin deterioration. In addition to salicylic acid-based and hesiphenone-based absorbents, triazole-based and cyanoacrylate-based ultraviolet absorbers are used for processing the resin. However, salicylic acid-based and benzophenone-based absorbents have a 300~
Absorption near 32 Onm is weak, and triazole-based absorbents are said to pose health and safety problems.

本発明が解決しようとする問題点 上述したごとく、化粧品及び樹脂の分野なとて種々の紫
外線吸収剤が開発されてはいるが、紫外線吸収能、安全
性、溶剤や樹脂への溶解性、および安定性をすべて満足
するものは未だ見いだされていないというのが実情であ
り、これらを兼備した紫外線吸収剤が望まれている。
Problems to be Solved by the Present Invention As mentioned above, various UV absorbers have been developed in the cosmetics and resin fields, but they lack UV absorbing ability, safety, solubility in solvents and resins, and The reality is that no one has yet been found that satisfies all of the stability requirements, and a UV absorber that has both of these properties is desired.

問題点を解決する為の手段 本発明者らは、かかる実情を鑑み、鋭意研究を行なった
結果、下記一般式(1)で表わされる新規α−デヒドロ
アミノ酸誘導体が表1に示すように中波長紫外線領域(
240〜360nm)に大きな吸収効果を有し、更に、
各種動植物油、油脂、および、有機溶剤に易溶であるこ
とから、これら新規α−デヒドロアミノ酸誘導体が皮膚
の紅斑防止、樹脂の劣化防止等に有効な紫外線吸収剤で
あることを見いだし、本発明を完成した。
Means for Solving the Problems In view of the above circumstances, the present inventors have conducted intensive research and have found that a novel α-dehydroamino acid derivative represented by the following general formula (1) has a medium wavelength property as shown in Table 1. UV range (
240 to 360 nm), and furthermore,
Since these novel α-dehydro amino acid derivatives are easily soluble in various animal and vegetable oils, fats and oils, and organic solvents, we have discovered that these novel α-dehydro amino acid derivatives are effective UV absorbers for preventing erythema on the skin and preventing deterioration of resins, etc., and have developed the present invention. completed.

XN    NCH2CH2C02R I+     (1) (但し、式1中、Xは水素原子又は−CH2−CH2C
02Rである。Rは炭素数8〜18のアルキル基、シク
ロヘキシル基又はトリメチルシクロへキシル基である。
XN NCH2CH2C02R I+ (1) (However, in formula 1, X is a hydrogen atom or -CH2-CH2C
It is 02R. R is an alkyl group having 8 to 18 carbon atoms, a cyclohexyl group, or a trimethylcyclohexyl group.

〉 本発明に係る一般式(1)表示のα−デヒドロアミノ酸
誘導体は、以下の方法により製造することができる。す
なわち、■芳香属アルデヒドと、ヒダントインの塩基触
媒による縮合、■生成したベンザールヒダントインに、
アクリル酸エステルをマイケル付加して、得られる。 
(式1)%式% HN       NH I HN       NH + CH2=CHC02R j −−−−−−→ X N     N CH2CH2C
02RC(1) (但し、式1中、Xは水素原子又は−CH2−CH2C
O2Rである。Rは炭素数3〜18のアルキル基、シク
ロヘキシル基又はトリメチルシクロヘキシル基である。
> The α-dehydroamino acid derivative represented by general formula (1) according to the present invention can be produced by the following method. That is, ■ base-catalyzed condensation of aromatic aldehyde and hydantoin, ■ the generated benzalhydantoin,
Obtained by Michael addition of acrylic acid ester.
(Formula 1) % formula % HN NH I HN NH + CH2=CHC02R j ---------→ X N N CH2CH2C
02RC(1) (However, in formula 1, X is a hydrogen atom or -CH2-CH2C
It is O2R. R is an alkyl group having 3 to 18 carbon atoms, a cyclohexyl group, or a trimethylcyclohexyl group.

) 本発明の一般式(1)表示の化合物を例示するならば、
4−ベンジリデン−2,5−ジオキソ−1,3−イミダ
ソリジンジプロピオン酸ジイソプルピルエステル、4−
ベンジリデン−2,5−ジオキソ−1,3−イミダソリ
ジンジプロピオン酸ジn−ブチルエステル、4−ベンジ
リデン−2,5−ジオキソ−1,3−イミダゾリジンジ
プロピオン酸ジイソブチルエステル、4−ベンジリデン
−2,5−ジオキソ−1,3−イミダゾリジンジプロピ
オン酸ビス(2−エチルヘキシルエステル)、4−ベン
ジリデン−2,5−ジオキソ−1−イミダゾリジンプロ
ピオン酸イソプロピルエステル、4−ベンジリデン−2
,5−ジオキソ−1−イミダゾリジンプロピオン酸 n
−ブチルエステル、4−ベンジリデン−2,5−ジオキ
ソ−1−イミダゾリジンプロピオン酸 イソブチルエス
テル、4ベンジリデン−2,5−ジオキソ−1−イミダ
ゾリジンプロピオン酸 2−エチルヘキシルエステル等
が挙げられる。
) Examples of compounds represented by general formula (1) of the present invention include:
4-Benzylidene-2,5-dioxo-1,3-imidasolidine dipropionic acid diisopropyl ester, 4-
Benzylidene-2,5-dioxo-1,3-imidazolidine dipropionic acid di-n-butyl ester, 4-benzylidene-2,5-dioxo-1,3-imidazolidine dipropionic acid diisobutyl ester, 4-benzylidene- 2,5-dioxo-1,3-imidazolidine dipropionate bis(2-ethylhexyl ester), 4-benzylidene-2,5-dioxo-1-imidazolidine propionate isopropyl ester, 4-benzylidene-2
,5-dioxo-1-imidazolidinepropionic acid n
-butyl ester, 4-benzylidene-2,5-dioxo-1-imidazolidine propionic acid isobutyl ester, 4-benzylidene-2,5-dioxo-1-imidazolidine propionic acid 2-ethylhexyl ester, and the like.

発明の効果 本発明に用いられる前記一般式(1)表示の新規ヒダン
トイン誘導体は、表1に示すように、270〜330n
mで、104以上の高い分子吸光係数を有し、皮膚の紅
斑の原因と考えられる290〜320nm、およびポリ
エチレン、ポリプロピレン、ポリ塩化ビニル等の樹脂の
劣化原因と考えられている300〜320nmの紫外線
に対し、高い吸収能を持つ。又、一般式(1)表示の化
合物は、Rの効果により、既存の化合物、例えば5−ベ
ンザールヒダントイン等に、比べ各種動植物油、油脂、
および有機溶剤に対する溶解性が、著しく向上し、クリ
ーム、乳)夜、ファンデーション、ヘアークリーム、日
焼は止め油等の化粧料に添加した際、安定な配合物を得
ることができる。また、これらの化合物をポリエチレン
、ポリプロピレン、ポリスチレン、ポリ塩化ビニル、A
BS樹脂、ポリカーボネートなどの樹脂に添加した場合
、樹脂との良い相溶性が期待できる。本発明に用いられ
る前記一般式(1)表示のヒダントイン誘導体を市販の
紫外線吸収剤(例えば、ベンゾフェノン系、トリアゾー
ル系、サリチル酸系吸収剤)と比較した場合、■殊に酸
素存在下に於ける紫外線の作用に対して優れた抑制効果
を有する。■熱安定性、光安定性が高く、効果の持続性
が良い。02〜10倍の紫外線分子吸光係数を有する。
Effects of the Invention As shown in Table 1, the novel hydantoin derivative represented by the general formula (1) used in the present invention has a molecular weight of 270 to 330n.
Ultraviolet rays of 290 to 320 nm, which have a high molecular extinction coefficient of 104 or more and are thought to cause skin erythema, and 300 to 320 nm, which are thought to cause deterioration of resins such as polyethylene, polypropylene, and polyvinyl chloride. However, it has a high absorption capacity. Furthermore, due to the effect of R, the compound represented by the general formula (1) is more effective than existing compounds, such as 5-benzalhydantoin, in various animal and vegetable oils, fats and oils,
The solubility in organic solvents is significantly improved, and stable formulations can be obtained when added to cosmetics such as creams, creams, night creams, foundations, hair creams, and sunscreen oils. In addition, these compounds can be used as polyethylene, polypropylene, polystyrene, polyvinyl chloride, A
When added to resins such as BS resin and polycarbonate, good compatibility with the resin can be expected. When the hydantoin derivative represented by the general formula (1) used in the present invention is compared with commercially available ultraviolet absorbers (for example, benzophenone-based, triazole-based, and salicylic acid-based absorbers), it is found that: It has an excellent suppressive effect on the effects of ■High thermal stability and photostability, and long-lasting effects. It has an ultraviolet molecular extinction coefficient of 0.2 to 10 times.

■各種重合体材料との相溶性が良好である為、繊維、樹
脂などの可塑剤として使用される一方、黄変防止剤とし
ても用いることができる等の効果がある。
■Since it has good compatibility with various polymer materials, it can be used as a plasticizer for fibers, resins, etc., and can also be used as an anti-yellowing agent.

上述したことく、本発明の用途範囲は、香粧品工業、プ
ラスチック工業、有機薬品工業、写真工業、食品工業、
繊維工業などであり、極めて広い。
As mentioned above, the scope of use of the present invention is the cosmetics industry, the plastics industry, the organic medicine industry, the photography industry, the food industry,
The textile industry is extremely wide.

殊に、紫外線吸収波長が、240〜360nm(最大吸
収波長 300〜340nm)にあり、香粧品に用いた
場合は、他に比類のない選択的吸収性をもった日焼け、
紅斑防止化粧品となり、また、ポリエチレン、ポリプロ
ピレン、ポリ塩化ビニルなど、重合体中に、混入した場
合、紫外線による劣化を、著しく軽減する。
In particular, the ultraviolet absorption wavelength is 240 to 360 nm (maximum absorption wavelength 300 to 340 nm), and when used in cosmetics, it is a tanning agent with unparalleled selective absorption.
It can be used as an anti-erythema cosmetic product, and when mixed into polymers such as polyethylene, polypropylene, and polyvinyl chloride, it significantly reduces deterioration caused by ultraviolet rays.

次に、本発明に係る代表的な化合物について、最大吸収
波長ならびに、その他の物性値を実施例1としてまとめ
て表1に示す。また実施例2に代表的な製法を示すが、
本発明はこれらの実施例によって限定されるものではな
い。
Next, the maximum absorption wavelength and other physical property values of typical compounds according to the present invention are summarized in Table 1 as Example 1. In addition, a typical manufacturing method is shown in Example 2,
The present invention is not limited to these examples.

実施例 2 合成例1 4−ベンジリデン−2,5−ジオキソ−1−イミダゾリ
ジンプロピオン酸 イソブチルエステルの合成 りMF150mlにベンザールヒダントイン20 g 
(0,106mo 1)、アクリル酸 イソブチルエス
テル 14.9g(0,117mol)及び、水酸化カ
リウム 1.2g(0,02m。
Example 2 Synthesis Example 1 Synthesis of 4-benzylidene-2,5-dioxo-1-imidazolidine propionic acid isobutyl ester 20 g of benzalhydantoin to 150 ml of MF
(0,106 mo 1), 14.9 g (0,117 mol) of acrylic acid isobutyl ester, and 1.2 g (0,02 m) of potassium hydroxide.

1)を、加える。110℃で2時間攪拌した後、冷却し
、反応液にトルエン300m lを加えて結晶化させた
。結晶を濾取後、乾燥し、4−ベンジリデン−2,5−
ジオキソ−1−イミダゾリジンプロピオン酸 イソブチ
ルエステル 27・ 2g(81%)を得た。
Add 1). After stirring at 110°C for 2 hours, the mixture was cooled, and 300 ml of toluene was added to the reaction mixture for crystallization. After collecting the crystals by filtration, they are dried to give 4-benzylidene-2,5-
27.2 g (81%) of dioxo-1-imidazolidine propionic acid isobutyl ester was obtained.

合成例2 4−ベンジリデン−2,5−ジオキソ−1,3−イミダ
ゾリジンジプロビオン酸 ビス(2−エチルヘキシルエ
ステル)の合成 りMFloomlにベンザールヒダントイン10g’(
53,1mmol)、アクリル酸 2−エチルヘキシル
 23.6g (127,6mm。
Synthesis Example 2 Synthesis of 4-benzylidene-2,5-dioxo-1,3-imidazolidine diprobionic acid bis(2-ethylhexyl ester) 10 g of benzalhydantoin (
53.1 mmol), 2-ethylhexyl acrylate 23.6 g (127.6 mm).

l)及び、水酸化カリウム 0. 6g (10,6m
mol)を、加える。110℃で2時間撹拌した後、冷
却した。酢酸エチルで抽出し、有機層を、水洗復硫酸ナ
トリウムで乾燥、減圧濃縮した。残さをトルエンに溶解
し、ヘキサンを加えて結晶化させた。結晶を濾取後、乾
燥し、4−ベンジリデン−2,5−ジオキソ−1,3−
イミダゾリジンジプロピオン酸 ビス(2−エチルヘキ
シルエステル)19.8g (42,3%)を得た。
l) and potassium hydroxide 0. 6g (10,6m
mol). After stirring at 110°C for 2 hours, it was cooled. The organic layer was extracted with ethyl acetate, washed with water, dried over sodium sulfate, and concentrated under reduced pressure. The residue was dissolved in toluene, and hexane was added for crystallization. After collecting the crystals by filtration, they were dried to give 4-benzylidene-2,5-dioxo-1,3-
19.8 g (42.3%) of imidazolidine dipropionic acid bis(2-ethylhexyl ester) was obtained.

Claims (1)

【特許請求の範囲】 下記一般式(1)で表わされる新規ヒダントイン誘導体
。 ▲数式、化学式、表等があります▼(1) (但し、式1中、Xは水素原子又は−CH_2−CH_
2CO_2Rである。Rは炭素数3〜18のアルキル基
、シクロヘキシル基又はトリメチルシクロヘキシル基で
ある。)
[Claims] A novel hydantoin derivative represented by the following general formula (1). ▲There are mathematical formulas, chemical formulas, tables, etc.▼(1) (However, in formula 1, X is a hydrogen atom or -CH_2-CH_
It is 2CO_2R. R is an alkyl group having 3 to 18 carbon atoms, a cyclohexyl group, or a trimethylcyclohexyl group. )
JP61246309A 1986-04-22 1986-10-16 New hydantoin derivative Expired - Lifetime JPH0798809B2 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
JP61246309A JPH0798809B2 (en) 1986-10-16 1986-10-16 New hydantoin derivative
US07/038,364 US4797493A (en) 1986-04-22 1987-04-14 Benzylidene compounds
DE19873713094 DE3713094A1 (en) 1986-04-22 1987-04-16 BENZYLIDE COMPOUNDS AND THEIR CONTAINING COSMETIC PREPARATIONS AND ULTRAVIOLET ABSORBERS
FR878705711A FR2597476B1 (en) 1986-04-22 1987-04-22 BENZYLIDENIC COMPOUNDS, COMPOSITIONS CONTAINING THE SAME, AND ULTRAVIOLET RADIATION ABSORBING AGENTS MADE THEREFROM.
KR1019870006755A KR900002058B1 (en) 1986-10-16 1987-07-01 Bernzylidene compounds cosmetic compositions containing the same and ultraviolet absorber comprising the same
US07/242,166 US5000945A (en) 1986-04-22 1988-09-08 Method of stabilizing a UVB absorbing compound, a stabilized UV absorber, and a cosmetic composition containing the same
US07/259,257 US4985237A (en) 1986-04-22 1988-10-18 Benzylidene compounds, cosmetic compositions containing the same and ultraviolet absorber comprising the same
US07/509,765 US5087729A (en) 1986-04-22 1990-04-17 Benzylidene compounds, cosmetic compositions containing the same and ultraviolet absorber comprising the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61246309A JPH0798809B2 (en) 1986-10-16 1986-10-16 New hydantoin derivative

Publications (2)

Publication Number Publication Date
JPS63101372A true JPS63101372A (en) 1988-05-06
JPH0798809B2 JPH0798809B2 (en) 1995-10-25

Family

ID=17146633

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61246309A Expired - Lifetime JPH0798809B2 (en) 1986-04-22 1986-10-16 New hydantoin derivative

Country Status (1)

Country Link
JP (1) JPH0798809B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01230559A (en) * 1988-03-11 1989-09-14 Sagami Chem Res Center 5-substituted methylidenehydantoin derivative

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4954369A (en) * 1972-06-16 1974-05-27
JPS5731669A (en) * 1980-06-21 1982-02-20 Degussa Manufacture of 5-arylidene hydantoin
JPS6245553A (en) * 1985-08-23 1987-02-27 Nippon Redarii Kk Production of phenylacetic acid derivative

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4954369A (en) * 1972-06-16 1974-05-27
JPS5731669A (en) * 1980-06-21 1982-02-20 Degussa Manufacture of 5-arylidene hydantoin
JPS6245553A (en) * 1985-08-23 1987-02-27 Nippon Redarii Kk Production of phenylacetic acid derivative

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01230559A (en) * 1988-03-11 1989-09-14 Sagami Chem Res Center 5-substituted methylidenehydantoin derivative

Also Published As

Publication number Publication date
JPH0798809B2 (en) 1995-10-25

Similar Documents

Publication Publication Date Title
US5000945A (en) Method of stabilizing a UVB absorbing compound, a stabilized UV absorber, and a cosmetic composition containing the same
CA2065117C (en) Benzalmalonate substituted s-triazine derivatives; process for preparing the same; filtering cosmetic compositions containing them and their use for protecting skin and hair against ultraviolet radiation
KR101312777B1 (en) Benzoic acid exter compounds, compositions, uses and methods related thereto
GB2225013A (en) Metal salts of benzylidene-camphor-sulphonic acids
CA2212256C (en) Indanylidene compounds, a process for their preparation and their use as uv absorbers
JP2000198762A (en) Oligomeric diarylbutadiene
US4797493A (en) Benzylidene compounds
JPH01502116A (en) Moisture resistant skin treatment composition
AU778388B2 (en) Use of cyclic enamines as light protection agents
GB2120549A (en) Sunscreen compositions
GB2081716A (en) Quaternary dibenzoylmethane derivatives and their use as sun filters
EP1123934A1 (en) Benzoxazole derivatives useful as UV filters
PT1471059E (en) 2,4,6-tris(dineopentyl 4`-aminobenzalmalonate)-s-triazin, sunscreen compositions containing this compound and its use
JPS63101372A (en) Novel hydantoin derivative
PT1677742E (en) Powdery preparations containing diethylamino-hydroxybenzoyl-hexyl-benzoate
JPS6236484A (en) Ultraviolet absorber
JP2010539230A (en) UV absorbing compounds
JP5022659B2 (en) Furylmethylenemalonamide compound and salts thereof, UV absorber, external preparation for skin
JP2008214341A (en) Ultraviolet-screening composition and cosmetic
JPS62249959A (en) Novel alpha-dehydroamino acid derivative
KR900002058B1 (en) Bernzylidene compounds cosmetic compositions containing the same and ultraviolet absorber comprising the same
AU713802B2 (en) Substituted benzylidenecyanoacetic esters
US4759926A (en) Sunscreen compositions
JPH0770084A (en) Benzylidene hydantoin derivative, ultraviolet light absorbent and skin external preparation blending the same absorbent
JPH0717892A (en) 1,3-butadienyl ketone derivative, ultraviolet ray absorber and skin external preparation containing the same blended therein

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term